AXGN – AxoGen, Inc.
AxoGen, Inc.AXGN
$18.00Name : AxoGen, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $792,149,376.00
EPSttm : -0.33
AxoGen, Inc.
$18.00
2.70%$0.5Float Short %
4.51
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
-0.05
EPS Last/This Y
EPS This/Next Y
0.23
Price
17.98
Target Price
21
Analyst Recom
1.14
Performance Q
40.62
Relative Volume
0.99
Beta
1.04
Ticker: AXGN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | AXGN | 18.67 | 0.03 | 0.55 | 1340 |
| 2025-01-24 | AXGN | 18.14 | 0.03 | 0.00 | 1355 |
| 2025-01-27 | AXGN | 17.88 | 0.03 | 0.86 | 1351 |
| 2025-01-28 | AXGN | 18.53 | 0.03 | 0.50 | 1356 |
| 2025-01-29 | AXGN | 18.32 | 0.03 | 42.00 | 1364 |
| 2025-01-30 | AXGN | 18.24 | 0.10 | 0.00 | 1448 |
| 2025-01-31 | AXGN | 18.21 | 0.10 | 0.00 | 1453 |
| 2025-02-03 | AXGN | 17.91 | 0.14 | 0.23 | 1512 |
| 2025-02-04 | AXGN | 18.09 | 0.14 | 0.00 | 1509 |
| 2025-02-05 | AXGN | 18.86 | 0.14 | 999.99 | 1516 |
| 2025-02-06 | AXGN | 18.32 | 0.21 | 0.00 | 1612 |
| 2025-02-07 | AXGN | 17.95 | 0.20 | 0.09 | 1661 |
| 2025-02-10 | AXGN | 17.69 | 0.21 | 0.00 | 1650 |
| 2025-02-11 | AXGN | 17.54 | 0.21 | 0.33 | 1656 |
| 2025-02-12 | AXGN | 17.8 | 0.21 | 0.00 | 1657 |
| 2025-02-13 | AXGN | 18.14 | 0.21 | 0.00 | 1667 |
| 2025-02-14 | AXGN | 18.12 | 0.21 | 0.06 | 1664 |
| 2025-02-18 | AXGN | 17.96 | 0.21 | 2.56 | 1668 |
| 2025-02-19 | AXGN | 18.68 | 0.20 | 0.00 | 1664 |
| 2025-02-20 | AXGN | 18.38 | 0.20 | 0.03 | 1666 |
| 2025-02-21 | AXGN | 17.99 | 0.20 | 0.32 | 1669 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | AXGN | 18.70 | 150.0 | - | 0.08 |
| 2025-01-24 | AXGN | 18.12 | 150.0 | - | 0.08 |
| 2025-01-27 | AXGN | 17.86 | 150.0 | - | 0.08 |
| 2025-01-28 | AXGN | 18.40 | 150.0 | - | 0.08 |
| 2025-01-29 | AXGN | 18.32 | 150.0 | - | 0.08 |
| 2025-01-30 | AXGN | 18.27 | 150.0 | - | 0.08 |
| 2025-01-31 | AXGN | 18.19 | 150.0 | - | 0.08 |
| 2025-02-03 | AXGN | 17.92 | 150.0 | - | 0.08 |
| 2025-02-04 | AXGN | 18.09 | 153.3 | - | 0.08 |
| 2025-02-05 | AXGN | 18.85 | 153.3 | - | 0.08 |
| 2025-02-06 | AXGN | 18.33 | 153.3 | - | 0.08 |
| 2025-02-07 | AXGN | 17.95 | 153.3 | - | 0.08 |
| 2025-02-10 | AXGN | 17.72 | 153.3 | - | 0.08 |
| 2025-02-11 | AXGN | 17.52 | 153.3 | - | 0.08 |
| 2025-02-12 | AXGN | 17.80 | 153.3 | - | 0.08 |
| 2025-02-13 | AXGN | 18.12 | 153.3 | - | 0.08 |
| 2025-02-14 | AXGN | 18.13 | 153.3 | - | 0.08 |
| 2025-02-18 | AXGN | 17.96 | 153.3 | - | 0.08 |
| 2025-02-19 | AXGN | 18.68 | 153.3 | - | 0.08 |
| 2025-02-20 | AXGN | 18.51 | 160.0 | - | 0.08 |
| 2025-02-21 | AXGN | 17.98 | 160.0 | - | 0.08 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | AXGN | 0.00 | 0.57 | 2.47 |
| 2025-01-24 | AXGN | 0.00 | 0.57 | 2.47 |
| 2025-01-27 | AXGN | 0.00 | 0.68 | 2.47 |
| 2025-01-28 | AXGN | 0.00 | 0.68 | 2.99 |
| 2025-01-29 | AXGN | 0.00 | 0.68 | 2.99 |
| 2025-01-30 | AXGN | 0.00 | 0.68 | 2.99 |
| 2025-01-31 | AXGN | 0.00 | 0.68 | 2.99 |
| 2025-02-03 | AXGN | 0.00 | 0.70 | 2.99 |
| 2025-02-04 | AXGN | 0.00 | 0.70 | 2.99 |
| 2025-02-05 | AXGN | 0.00 | 0.70 | 2.99 |
| 2025-02-06 | AXGN | 0.00 | 0.70 | 2.99 |
| 2025-02-07 | AXGN | 0.00 | 0.70 | 2.99 |
| 2025-02-10 | AXGN | 0.00 | -2.00 | 3.01 |
| 2025-02-11 | AXGN | 0.00 | -2.00 | 3.01 |
| 2025-02-12 | AXGN | 0.00 | -2.00 | 4.54 |
| 2025-02-13 | AXGN | 0.00 | -2.00 | 4.54 |
| 2025-02-14 | AXGN | 0.00 | -2.00 | 4.51 |
| 2025-02-18 | AXGN | 0.00 | -3.48 | 4.51 |
| 2025-02-19 | AXGN | 0.00 | -3.48 | 4.51 |
| 2025-02-20 | AXGN | 0.00 | -3.48 | 4.51 |
| 2025-02-21 | AXGN | 0.00 | -3.48 | 4.51 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.07
Avg. EPS Est. Current Quarter
0.03
Avg. EPS Est. Next Quarter
0.02
Insider Transactions
Institutional Transactions
-3.48
Beta
1.04
Average Sales Estimate Current Quarter
47
Average Sales Estimate Next Quarter
47
Fair Value
Quality Score
53
Growth Score
48
Sentiment Score
86
Actual DrawDown %
24.9
Max Drawdown 5-Year %
-84.6
Target Price
21
P/E
Forward P/E
55.38
PEG
P/S
4.38
P/B
7.97
P/Free Cash Flow
EPS
-0.33
Average EPS Est. Cur. Y
0.08
EPS Next Y. (Est.)
0.32
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7.91
Relative Volume
0.99
Return on Equity vs Sector %
-33.6
Return on Equity vs Industry %
-26.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
AxoGen, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 426
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
stock quote shares AXGN – AxoGen, Inc. Stock Price stock today
news today AXGN – AxoGen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AXGN – AxoGen, Inc. yahoo finance google finance
stock history AXGN – AxoGen, Inc. invest stock market
stock prices AXGN premarket after hours
ticker AXGN fair value insiders trading